Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1380233
European Journal of Endocrinology, Vol 138, Issue 3, 233-239
Copyright © 1998 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Velho, G
Right arrow Articles by Froguel, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Velho, G
Right arrow Articles by Froguel, P

Articles

Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young

G Velho and P Froguel

INSERM U-342, Hopital Saint Vincent de Paul, Paris, France.

Maturity onset diabetes of the young (MODY) is a genetically and clinically heterogeneous subtype of non-insulin-dependent diabetes mellitus (NIDDM) characterised by early onset, autosomal dominant inheritance and a primary defect in insulin secretion. To date, three MODY genes have been identified on chromosomes 20q (MODY1/hepatic nuclear factor (HNF)-4alpha), 7p (MODY2/glucokinase) and 12q (MODY3/HNF-1alpha). Mutations in MODY2/glucokinase result in mild chronic hyperglycaemia as a result of reduced pancreatic beta-cell responsiveness to glucose, and decreased net accumulation of hepatic glycogen and increased hepatic gluconeogenesis after meals. In contrast, MODY1 and MODY3 are characterised by severe insulin secretory defects, and by major hyperglycaemia associated with microvascular complications. The role of the three known MODY genes in susceptibility to the more common late-onset NIDDM remain uncertain. Genetic studies seem to exclude a role as major susceptibility genes, but leave unresolved whether they may have a minor role in a polygenic context or an important role in particular populations.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
R. Barrio, C. Bellanne-Chantelot, J. C. Moreno, V. Morel, H. Calle, M. Alonso, and C. Mustieles
Nine Novel Mutations in Maturity-Onset Diabetes of the Young (MODY) Candidate Genes in 22 Spanish Families
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2532 - 2539.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
L B Johnston, A J L Clark, and M O Savage
Genetic factors contributing to birth weight
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2002; 86(1): F2 - 3.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Gerrish, M. A. Cissell, and R. Stein
The Role of Hepatic Nuclear Factor 1alpha and PDX-1 in Transcriptional Regulation of the pdx-1 Gene
J. Biol. Chem., December 14, 2001; 276(51): 47775 - 47784.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. A. Hagenfeldt-Johansson, P. L. Herrera, H. Wang, A. Gjinovci, H. Ishihara, and C. B. Wollheim
{beta}-Cell-Targeted Expression of a Dominant-Negative Hepatocyte Nuclear Factor-1{alpha} Induces a Maturity-Onset Diabetes of the Young (MODY)3-Like Phenotype in Transgenic Mice
Endocrinology, December 1, 2001; 142(12): 5311 - 5320.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
A. L Fowden and D. J Hill
Intra-uterine programming of the endocrine pancreas
Br. Med. Bull., November 1, 2001; 60(1): 123 - 142.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Westerlund and P. Bergsten
Glucose Metabolism and Pulsatile Insulin Release From Isolated Islets
Diabetes, August 1, 2001; 50(8): 1785 - 1790.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
L. Tappy, E. Jequier, and P. Schneiter
Autoregulation of Glucose Production
Physiology, August 1, 2000; 15(4): 198 - 202.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
G. Emilien, M. Ponchon, C. Caldas, O. Isacson, and J.-M. Maloteaux
Impact of genomics on drug discovery and clinical medicine
QJM, July 1, 2000; 93(7): 391 - 423.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Arizmendi, S. Liu, C. Croniger, V. Poli, and J. E. Friedman
The Transcription Factor CCAAT/Enhancer-binding Protein beta  Regulates Gluconeogenesis and Phosphoenolpyruvate Carboxykinase (GTP) Gene Transcription during Diabetes
J. Biol. Chem., May 7, 1999; 274(19): 13033 - 13040.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Roduit, J. Morin, F. Masse, L. Segall, E. Roche, C. B. Newgard, F. Assimacopoulos-Jeannet, and M. Prentki
Glucose Down-regulates the Expression of the Peroxisome Proliferator-activated Receptor-alpha Gene in the Pancreatic beta -Cell
J. Biol. Chem., November 10, 2000; 275(46): 35799 - 35806.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 European Society of Endocrinology.